Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $2.0M | $15.2M | $20.4M | $18.7M | $9.8M | $12.1M | $15.0M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $6.3M | $2.0M | $15.2M | $20.4M | $18.7M | $9.8M | $12.1M | $15.0M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$4.8M | $375.9K | −$1.2M | $1.4M | −$1.0M | −$1.4M | −$266.0K | $864.3K |
| EBITDA | $0 | $403.9K | $0 | $1.6M | −$737.0K | −$1.1M | −$78.3K | $1.1M |
| Net income | −$257.0K | $8.0K | −$849.0K | $627.8K | −$1.4M | −$2.9M | −$476.0K | $1.2M |
| Net margin | -4.1% | 0.4% | -5.6% | 3.1% | -7.6% | -29.4% | -3.9% | 8.0% |
| EPS (diluted) | -0.21 | 0.14 | -0.39 | 0.21 | -0.54 | -1.07 | -0.14 | 0.35 |
Annual figures · source: Financial Modeling Prep
DETWILER FENTON GROUP INC
No one on the platform currently holds DMCD.
No tracked institution reports a position in DMCD as of their last filing.
| Execution date | Ratio |
|---|---|
| 2004-05-26 | 600-for-1 |
| 2004-05-26 | 1-for-600reverse |
No one on the platform has traded DMCD yet.
| $614 |
| — |
| LXGTFLexington Biosciences, Inc. | $0.00 | +0.00% | $379 | — |
| NVPLFNevaro Capital Corporation | $0.00 | +0.00% | $393 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.